Vycor Medical (VYCO) Income from Continuing Operations (2010 - 2026)
Vycor Medical's (VYCO) quarterly Income from Continuing Operations came in at 20095.0 in Q1 2026, up 152.18% year-on-year from 7968.65 in Q1 2025, and up 132.21% on a QoQ basis from 62379.0 in Q4 2025.
Vycor Medical (VYCO) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Income from Continuing Operations data on file, last reported at 20095.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 152.18% year-over-year to 20095.0 in Q1 2026; TTM through Mar 2026 was 11581.0, a 87.11% increase from a year earlier, with the FY2025 full-year figure at 55450.0, up 6.61% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 20095.0, up from 62379.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for VYCO reached as high as 261471.0 in Q4 2022 and fell as low as 112312.0 in Q3 2022.
- Historically, Income from Continuing Operations has averaged 12786.65 across 5 years, with a median of 30507.0 in 2024.
- Across the five-year window, Income from Continuing Operations plunged 10463.31% in 2022 and soared 357.41% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 261471.0 in 2022, then tumbled by 134.41% to 89961.0 in 2023, then surged by 120.49% to 18432.0 in 2024, then slumped by 438.43% to 62379.0 in 2025, then jumped by 132.21% to 20095.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 20095.0 in Q1 2026, 62379.0 in Q4 2025, and 4990.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 20,095.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,095.00 |
| Dec 31, 2025 | -62,379.00 |
| Sep 30, 2025 | 4,990.00 |
| Jun 30, 2025 | 25,713.00 |
| Mar 31, 2025 | -38,514.00 |
| Dec 31, 2024 | 18,432.00 |
| Sep 30, 2024 | -59,770.00 |
| Jun 30, 2024 | -9,989.00 |
| Mar 31, 2024 | -30,507.00 |
| Dec 31, 2023 | -89,961.00 |
| Sep 30, 2023 | -51,479.00 |
| Jun 30, 2023 | 70,791.00 |
| Mar 31, 2023 | 7,569.00 |
| Dec 31, 2022 | 261,471.00 |
| Sep 30, 2022 | -112,312.00 |
| Jun 30, 2022 | -97,726.00 |
| Mar 31, 2022 | -73,797.00 |
| Dec 31, 2021 | 185,019.00 |
| Sep 30, 2021 | 7,659.00 |
| Jun 30, 2021 | 943.00 |